SEC Form D private-offering filing

Vinci Pharmaceuticals, Inc.

Name: Vinci Pharmaceuticals, Inc. - new SEC Form D private-offering filing, Avon By The Sea, NJ
Published: 2026-01-26

A new SEC Form D private-offering notice from Avon By The Sea, NJ, a $25,348,339 filer-stated offering target in Biotech. The source filing is one click away.

Vinci Pharmaceuticals, Inc. site↗ Verified via SEC Form D

Specialty ophthalmic company developing EPIPLANT, a needle free drug delivery platform for retinal diseases including diabetic macular edema and intermediate age related macular degeneration.

Filed 2026-01-26Filed to raise $25,348,339First money in 2026-01-02Raised so far $20,218,331HQ (as filed) Avon By The Sea, NJSector Biotech ✓Stage (inferred) GrowthCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified vincipharmaceuticals.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in New Jersey →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.